Try our mobile app

General information

Country: UNITED STATES

Sector: Drug Manufacturers — General

Categories: @vaccine-makers   

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Website: pfizer.com


  • Good financial results growth rate 12.3% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (3.3%)
  • Dividend yield for the last twelve months 6.3%
  • Free cash flow yield 0.0% (LTM)
  • Share price is 8.4% higher than minimum and 51.3% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (14.2x vs
    )
  • For the last 3 months insiders bought company shares on $0.5 mln (0.000% of cap.)

Key Financials (Download financials)

Ticker: PFE
Share price, USD:  (+0.9%)26.885
year average price 27.60  


year start price 26.89 2024-02-27

max close price 31.39 2024-07-30

min close price 24.80 2024-11-15

current price 26.89 2025-02-25
Common stocks: 5 615 000 000

Dividend Yield:  6.3%
EV / LTM EBITDA: 14.2x
EV / EBITDA annualized: 24.8x
Target EV / EBITDA (hist percentile):
Express share price potential:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 150 959
Net Debt ($m): 58 021
EV (Enterprise Value): 208 980
EBITDA LTM ($m): 14 764
EV / LTM EBITDA: 14.2x
Price to Book: 1.6x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-02-25zacks.com

Summit Incurs In-Line Q4 Loss, Inks Collaboration Deal With Pfizer

2025-02-24prnewswire.com

Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination with Pfizer's ADCs

2025-02-24reuters.com

Pfizer names former FDA director Patrizia Cavazzoni as chief medical officer

2025-02-24seekingalpha.com

Pfizer: What The Summit Therapeutics Deal Brings

2025-02-24globenewswire.com

INVESTIGATION ALERT: Berger Montague PC Investigates Pfizer Inc.'s Board Of Directors For Breach of Fiduciary Duties (NYSE: PFE)

2025-02-22seekingalpha.com

Pfizer: No More Growth - Still A Worthy Dividend Buy

2025-02-21fool.com

2 No-Brainer Healthcare Stocks to Buy With $500 Right Now

2025-02-20reuters.com

Pfizer says it will end global development of gene therapy Beqvez, Nikkei reports

2025-02-19seekingalpha.com

Why Pfizer's Stock Price Isn't Reflecting Its True Value

2025-02-19seekingalpha.com

Pfizer Stock's Upside Got Bigger
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data